FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2018/06/014474 [Registered on: 08/06/2018] Trial Registered Prospectively
Last Modified On: 07/06/2018
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Biological
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A Clinical Trial to see the effect of some Ayurvedic Formulation in the treatment of Vataja Abhishyanda with reference to Allergic Conjunctivitis 
Scientific Title of Study   Randomized Clinical Controlled Trial to study the effect of Bilva Panchmooladi Kwath Siddha Ghrita Aschyotana and Olopatadine Eye Drops in Vataja Abhishyanda. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Vd Supriya Suryakant Muddalwar 
Designation  MS Scholar  
Affiliation  Sumatibhai Shah Ayurved Mahavidyalaya 
Address  OPD no. 09, Department of Shalakyatantra, Sane Guruji Arogya Kendra, Hadapsar, Pune.
Malwadi Road, Hadapsar, Pune.
Pune
MAHARASHTRA
411028
India 
Phone  8668844115  
Fax    
Email  smuddalwar@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Nilakshi Shekhar Pradhan 
Designation  Professor and Head of Department 
Affiliation  Sumatibhai Shah Ayurved Mahavidyalaya 
Address  OPD no. 09, Department of Shalakyatantra, Sane Guruji Arogya Kendra, Hadapsar, Pune.
Malwadi Road, Hadapsar, Pune.
Pune
MAHARASHTRA
411028
India 
Phone  9423580963  
Fax    
Email  drnspradhan@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Vd Supriya Suryakant Muddalwar 
Designation  MS Scholar  
Affiliation  Sumatibhai Shah Ayurved Mahavidyalaya 
Address  OPD no. 09, Department of Shalakyatantra, Sane Guruji Arogya Kendra, Hadapsar, Pune.
Malwadi Road, Hadapsar, Pune.
Pune
MAHARASHTRA
411028
India 
Phone  8668844115  
Fax    
Email  smuddalwar@gmail.com  
 
Source of Monetary or Material Support  
Department of Shalakyatantra, Sane Guruji Arogya Kendra, Malwadi road, Hadapsar, Pune.  
 
Primary Sponsor  
Name  Sane Guruji Arogya Kendra 
Address  Malwadi road, Hadapsar, Pune. 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Vd Supriya Suryakant Muddalwar  Sane Guruji Arogya Kendra, Hadapsar.  PD no 09, Shalakyatantra department, Sane Guruji Arogya Kendra, Malwadi road, Hadapsar, Pune.
Pune
MAHARASHTRA 
8668844115

smuddalwar@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Vataja Abhishyanda, Allergic Conjunctivitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Bilva Panchamooladi Kwath Siddha Ghrita Aschyotana  Bilva,Agnimantha,Shonyak,Patala,Gambhari,Brihati,Eranda,Shigru Siddha Ghrita Dose-1drop twice a day Frequency-Twice a day Administration-Topical Duration-10 days 
Comparator Agent  Olopatadine Eye drops  Olopatadine is Anti- Histaminic used in the treatment of Allergic Conjunctivitis. Dose- One drop Frequency- Twice a day Administration- Topical instillation Duration- 10 days 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients suffering from symptoms of Vataja Abhishyanda-Toda,Sangharsha,Shishirashruta,Alpa shopha 
 
ExclusionCriteria 
Details  Pittaja,Kaphaja,Raktaja Abhishyanda
other complications like corneal opacity,corneal ulcer
Systemic diseases like Broncheal Asthama,Allergic Bronchitis,Dermatitis,Allergic Rhinitis,DM,HTN etc will be excluded. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Effect of Bilva Panchmooladi kwath siddha ghrita in vataja abhishyanda.  The drug will be given for 10 days. The patients will be assessed before and after treatment. Total duration of study will be 18 months. 
 
Secondary Outcome  
Outcome  TimePoints 
To get relief from symptoms of Vataja Abhishyanda  18 months 
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1 
Date of First Enrollment (India)   20/06/2018 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   None yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   This study is open labeled clinical trial to see the effect of Bilva Panchamooladi Kwath Siddha Ghrita Aschyotana instilled twice daily for 10 days in eye/eyes of patients affected with Vataja Abhishyanda. The primary outcome will be effect of Aschyotana in Vataja Abhishyanda.
 
Close